Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| The Physicians' Services Incorporated Foundation | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This proposal aims to provide some objective, non-invasively achieved, physiologically relevant data in order to provide some rational basis for decision-making for transfusion in sTBI. Specifically this proposal is an observational study of transfusion and brain tissue saturation in sTBI patients. The results will illustrate to what degree brain tissue oxygenation is critically dependent on the degree of anemia in sTBI and help in the decision of whether transfusion might be helpful.
While there are studies that have invasively monitored cerebral saturation and brain tissue oxygen in severe traumatic brain injury (sTBI) patients, there are none using non-invasive cerebral saturation monitoring in TBI patients undergoing packed red blood cell (pRBC) transfusion. To date, all published studies have involved invasive monitoring with their concomitant potential side effects. Insertion of invasive probes and monitors has several risks and side effects including bleeding, local trauma and brain damage, and infection. Furthermore, they have limited utility as information is restricted to the region of the brain surrounding the probe, as opposed to a more global picture. We therefore propose an observational study using non-invasive near infrared spectroscopy to monitor brain tissue oxygen during the transfusion of packed red blood cells.
Primary Hypothesis:
• Improved oxygen delivery causes improved brain tissue oxygen saturation.
Testable Hypothesis:
• The transfusion of packed red blood cells resulting in a change in the hemoglobin in the 70- 100g/L range, will be associated with an increase in cerebral tissue oxygen saturation measured by near infrared spectroscopy in severe traumatic brain injured patients.
Primary Aims:
• Evaluate the applicability of a 4 wavelength near-infrared spectroscopy (NIRS) to monitor the cerebral oximetry in traumatic brain injury patients. Observe the trend of cerebral tissue oxygenation saturations (StO2) before, during and after a blood transfusion in TBI patients.
Secondary Hypothesis:
Secondary Aims:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Applicability of a 4 wavelength near-infrared spectroscopy (NIRS) to monitor the CHANGE in absolute cerebral oximetry over time | After the physician in charge for the patient decides a PRBC transfusion is needed, the FORE-SIGHT probe will be placed on the patient's forehead. A single PRBC unit will be transfused over 30 - 60 minutes. Recording will be started 60 minutes before the transfusion and continued for up to 10 hours after the PRBC unit. | Compare the change from the start of the transfusion until 10 hours later. |
| Measure | Description | Time Frame |
|---|---|---|
| The impact of PRBC transfusion on absolute cerebral oximetry compared to peripheral values over time. | Blood specimens (2-4 ml each every 30-60 minutes up to 5 hours) will be drawn concurrently with the routine blood work ordered by the clinical team. The additional blood work will be drawn from an arterial line or central line already in place so no needles will be used, thus minimizing the risk further. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Inability to place the NIRS probes on the patients (facial fractures, facial laceration, etc.).
Deficient signal of SctO2 impeding its proper valuation
Active coronary ischemia as judged by dynamic ischemic ECG changes and/ or positive troponin levels not due to myocardial contusion.
Active hemorrhage: Example
Clinical diagnosis of drug or alcohol intoxication as predominant cause of coma
Systolic BP <90mmHg
Heart rate > 120bpm
GCS=3 + un-reactive pupils
Not provided
Not provided
30 Patient with clinical diagnosis of severe TBI and GCS <9 and Age > 18 years old
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Andrew Baker, MD | Medical Director, Critical Care | Study Director |
| Victoria A McCredie, MBChB | Sunnybrook Health Sciences Center, University of Toronto | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| St Michael's Hospital | Toronto | Ontario | M5B 1W8 | Canada |
Not provided
| ID | Term |
|---|---|
| D000070642 | Brain Injuries, Traumatic |
| D001930 | Brain Injuries |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
Not provided
Not provided
Not provided
Not provided
Not provided
| Level of hemoglobin and hematocrit on admission, before transfusion and hourly after the transfusion for up to 5 hours |
| D020196 | Trauma, Nervous System |
| D014947 | Wounds and Injuries |